These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 25330296)

  • 1. The Tsk2/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene.
    Long KB; Li Z; Burgwin CM; Choe SG; Martyanov V; Sassi-Gaha S; Earl JP; Eutsey RA; Ahmed A; Ehrlich GD; Artlett CM; Whitfield ML; Blankenhorn EP
    J Invest Dermatol; 2015 Mar; 135(3):718-27. PubMed ID: 25330296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The tight skin 2 mouse. An animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration.
    Christner PJ; Peters J; Hawkins D; Siracusa LD; Jiménez SA
    Arthritis Rheum; 1995 Dec; 38(12):1791-8. PubMed ID: 8849351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tight skin 2 mice exhibit a novel time line of events leading to increased extracellular matrix deposition and dermal fibrosis.
    Long KB; Artlett CM; Blankenhorn EP
    Matrix Biol; 2014 Sep; 38():91-100. PubMed ID: 24820199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of collagen gene expression in the Tsk2 mouse.
    Barisic-Dujmovic T; Boban I; Clark SH
    J Cell Physiol; 2008 May; 215(2):464-71. PubMed ID: 17960558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activation of the alpha1(I) procollagen gene and up-regulation of alpha1(I) and alpha1(III) procollagen messenger RNA in dermal fibroblasts from tight skin 2 mice.
    Christner PJ; Hitraya EG; Peters J; McGrath R; Jiménez SA
    Arthritis Rheum; 1998 Dec; 41(12):2132-42. PubMed ID: 9870870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
    Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
    Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III collagen affects dermal and vascular collagen fibrillogenesis and tissue integrity in a mutant Col3a1 transgenic mouse model.
    D'hondt S; Guillemyn B; Syx D; Symoens S; De Rycke R; Vanhoutte L; Toussaint W; Lambrecht BN; De Paepe A; Keene DR; Ishikawa Y; Bächinger HP; Janssens S; Bertrand MJM; Malfait F
    Matrix Biol; 2018 Sep; 70():72-83. PubMed ID: 29551664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demonstration of autoimmunity in the tight skin-2 mouse: a model for scleroderma.
    Gentiletti J; McCloskey LJ; Artlett CM; Peters J; Jimenez SA; Christner PJ
    J Immunol; 2005 Aug; 175(4):2418-26. PubMed ID: 16081813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.
    Stembridge NS; Vandersteen AM; Ghali N; Sawle P; Nesbitt M; Pollitt RC; Ferguson DJ; Holden S; Elmslie F; Henderson A; Hulmes DJ; Pope FM
    Am J Med Genet A; 2015 Aug; 167A(8):1763-72. PubMed ID: 25846194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of alpha 1(III) procollagen gene in Tsk2/+ dermal fibroblasts.
    Christner PJ; Yufit T; Peters J; McGrath R; Conway RF; Jiménez SA
    Biochem Biophys Res Commun; 2003 Apr; 303(2):406-12. PubMed ID: 12659831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
    Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
    Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight Skin 2 Mice Exhibit Delayed Wound Healing Caused by Increased Elastic Fibers in Fibrotic Skin.
    Long KB; Burgwin CM; Huneke R; Artlett CM; Blankenhorn EP
    Adv Wound Care (New Rochelle); 2014 Sep; 3(9):573-581. PubMed ID: 25207200
    [No Abstract]   [Full Text] [Related]  

  • 13. Type III collagen (COL3A1): Gene and protein structure, tissue distribution, and associated diseases.
    Kuivaniemi H; Tromp G
    Gene; 2019 Jul; 707():151-171. PubMed ID: 31075413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation screening system for Ehlers-Danlos Syndrome, vascular type by high-resolution melting curve analysis in combination with small amplicon genotyping using genomic DNA.
    Naing BT; Watanabe A; Shimada T
    Biochem Biophys Res Commun; 2011 Feb; 405(3):368-72. PubMed ID: 21219851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the tight skin (Tsk1/+) mouse as a model for testing antifibrotic agents.
    Baxter RM; Crowell TP; McCrann ME; Frew EM; Gardner H
    Lab Invest; 2005 Oct; 85(10):1199-209. PubMed ID: 16127425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptome analysis of skin fibroblasts with dominant negative COL3A1 mutations provides molecular insights into the etiopathology of vascular Ehlers-Danlos syndrome.
    Chiarelli N; Carini G; Zoppi N; Ritelli M; Colombi M
    PLoS One; 2018; 13(1):e0191220. PubMed ID: 29346445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Optimal Mouse Models of Systemic Sclerosis by Interspecies Comparative Genomics.
    Sargent JL; Li Z; Aliprantis AO; Greenblatt M; Lemaire R; Wu MH; Wei J; Taroni J; Harris A; Long KB; Burgwin C; Artlett CM; Blankenhorn EP; Lafyatis R; Varga J; Clark SH; Whitfield ML
    Arthritis Rheumatol; 2016 Aug; 68(8):2003-15. PubMed ID: 26945694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
    Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
    J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new COL3A1 mutation in Ehlers-Danlos syndrome type IV.
    Eder J; Laccone F; Rohrbach M; Giunta C; Aumayr K; Reichel C; Trautinger F
    Exp Dermatol; 2013 Mar; 22(3):231-4. PubMed ID: 23489429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.